Interleukin-18 (IL-18) has been found to have multiple effects upon various cells involved in inflammatory response. Recently we reported that B16 murine
melanoma cells are able to produce
IL-18, which is involved in the regulation of intracellular
reactive oxygen intermediates (ROI) and
Fas-ligand expression, indicating that
IL-18 plays key role in the
tumor activity of
melanoma. In this study, we investigated the pattern of
IL-18 expression in the human system.
IL-18 production was tested by
enzyme linked
immunosorbent assay (ELISA) assay in various tumor cell lines, including Raji (
Burkitt's lymphoma), IM-9 (B lymphoblast), Jurkat (
acute T cell leukemia), SK-MES-1 (
squamous cell carcinoma (SCC) cell line), SK-MEL-2, G-361, DM-4, and DX-3 (
melanoma cell lines). ELISA tests showed that
IL-18 was highly expressed in malignant skin
tumors such as SK-MES-1, SK-MEL-2, G-361, DM-4, and DX-3 cell lines, thus suggesting that
IL-18 production may be associated with the
malignancy of skin
tumors. Here, we report that enhanced
IL-18 expression is positively correlated with malignant skin
tumors such as SCC and
melanoma, suggesting the importance role of
IL-18 in
malignancy of skin
tumors. Taken together, expression of
IL-18 by
tumor cells in human skin tissue may provide an important clue to understand the pathogenesis of malignant skin
tumors.